Overview

Treatment of Severe Hypertension During Pre-Eclampsia: A Preliminary Equivalence Study Between Urapidil and Nicardipine

Status:
Unknown status

Trial end date:
2010-08-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to confirm that URAPIDIL is as efficient and as safe as NICARDIPINE to correct severe hypertension in pre-eclamptic patients. - efficacy endpoint : mean arterial blood pressure corrected to 105-125 mmHg after 120 min of study drug administration. - safety endpoints : clinical, biological and ultrasound observation for any side effect.All infants will be observed in the neonatology unit (during 48h).

Phase:

Phase 3

Details

Lead Sponsor:

University Hospital, Strasbourg, France

Treatments:

Nicardipine
Urapidil